SwitzerlandSwiss Lab Develops Implantable Brain Chip for Mood Disorder Treatment
EPFL neurotechnology lab in Switzerland has developed an implantable brain chip called 'LogSync' to measure brain activity and deliver electrical stimulation for treating mood and anxiety disorders, funded by a US grant.
Background
Brain-computer interface technology is an emerging field with significant research and development in both medical and technological sectors. Switzerland and the US are key players in advancing neurotechnology, aiming to address neurological and mental health conditions through innovative solutions.
Quorum · collective opinions
Swiss Lab Develops Implantable Brain Chip for Mood Disorder Treatment
First report 22h agoLast update 4h ago1 takes 1
factual reportingneutralShow 4 posts
started 22h ago•Last update 4h ago
Reporting on the development and funding of a new neurotechnology implant for mental health treatment.
iWitness comments
No comments yet — be the first to weigh in.